A phase 2, open-label, single-arm, prospective, multicenter study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer Meeting Abstract
| Authors: | Dockery, L.; Musa, F.; Mathews, C.; Spirtos, N.; Slomovitz, B.; Priebe, A.; Green, A.; Puechl, A.; Birrer, M.; Herzog, T.; Ding, L.; Schmid, A.; Navarro, W.; Moore, K. |
| Abstract Title: | A phase 2, open-label, single-arm, prospective, multicenter study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer |
| Meeting Title: | IGCS 2024 Annual Meeting |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 34 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2024 Oct 16-18 |
| Meeting Location: | Dublin, Ireland |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2024-10-01 |
| Start Page: | A348 |
| Language: | English |
| ACCESSION: | WOS:001443842300021 |
| DOI: | 10.1136/ijgc-2024-IGCS.606 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TP004/#1561 -- Source: Wos |
